A new peer-to-peer review video demonstrates how effective patient-specific implants can be in treating lumbar deformities with anterior/posterior fusion.
This video features a surgical procedure using the aprevo® interbody device. Thank you Lauren E. Stone, M.D. and Joseph A. Osorio, M.D. for advancing personalized spine surgery. Building clinical evidence is what we do at Carlsmed. To view use this link https://bit.ly/3RmbNXw. #aprevo #personalizedmedicine #getyourpowerback #patientspecific #neurosurgeon #neurosurgery
Read More: https://www.linkedin.com/posts/carlsmed_360-totum-alif-for-a-symptomatic-fractional-activity-6971516873561534464-xYdZ/?utm_source=share&utm_medium=member_desktop
Via: Carlsmed Via: Mass Device Outset Medical (Nasdaq:OM) announced today that it has won a national contract with the U.S. Department of Veterans Affairs to sell its Tablo hemodialysis system into the department’s 106 VA hospitals. Via: Outset Medical Water quality depends on many “highly fluid” variables. It is the most important component in a safe and successful hemodialysis treatment, in any setting. Here we look at a few key impacts on water that are critical in protecting patients’ health. Via: NeuroNews Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint operating platform. Via: Bakersfield SAN MATEO, Calif., June 06, 2022 -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the publication of initial results of the SUMMIT NZ clinical trial, a single-arm, multi-center, prospective trial evaluating the proprietary Monopoint operating platform. Results from the first 45 patients demonstrated that the Monopoint platform yielded an 80% first pass effect (FPE1) with primary use of the HiPoint™ 88 (.088in ID) catheter, a super-bore catheter designed to consistently reach the proximal middle cerebral artery (MCA). The Route 92 HiPoint 88 aspiration catheter successfully reached the proximal MCA (M1 segment) in 100% of the cases attempted. The results were published in the Journal of NeuroInterventional Surgery online2. Digital Care for Chronic Musculoskeletal Pain: 10,000 Participant Longitudinal Cohort Study6/3/2022
Via: Hinge Health Chronic musculoskeletal pain has a vast global prevalence and economic burden. Conservative therapies are universally recommended but require patient engagement and self-management to be effective. This study aimed to evaluate the efficacy of a 12-week digital care program (DCP) in a large population of patients with chronic knee and back pain. Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients6/2/2022
Via: GlobalNewswire SUNNYVALE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety Organization (SVS PSO) and their Vascular Quality Initiative (VQI), has expanded coverage for TCAR to include standard surgical risk patients within the VQI’s TCAR Surveillance Project (TSP). This decision is effective immediately and comes on the heels of the recent Food and Drug Administration (FDA) approval for expanded indications for the ENROUTE® Transcarotid Stent System to include patients at high risk and standard risk for adverse events from carotid endarterectomy (CEA). Via: Coverage Healthy lifestyle changes, such as eating healthy food, and being active, can help – and now, there are new digital support options like Omada. Wei-Li Shao, president of Omada Health, provides insight on financial trends in digital health investment, and what the virtual-first care approach means for the future of health care. Via: Health Evolution When Sean Duffy co-founded Omada Health in 2011, the pursuit was to reinvent how people manage chronic disease. |
Archives
September 2022
|